The Supriya Lifescience IPO (Initial Public Offering) was subscribed 71.47 times by the end of 20 December 2021. It received 1,03,82,75,874 bids against an allotment of 1,45,28,299 equity shares on the final day of subscription. Supriya Lifescience is one of the country’s top manufacturers and suppliers of APIs (active pharmaceutical ingredients). The company produces 38 APIs in various …